Partial replicate design & ABE for the FDA [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2017-03-06 18:49 (3383 d 04:00 ago) – Posting: # 17142
Views: 13,869

❝ Nice location, btw. ;-)


Yep.

❝ (you still have the list of participants? ***glotz***)


Can’t remember whether one existed. I only have the list of organizers and speakers.

❝ Re. Test better than Ref: But you can't know in advance …


Only an educated guess from a pilot.

❝ … and if you have a look at some of the "companies" nowadays "developing" generics your "gut feeling"/experience from the past might be subjected to some change (as so many things nowadays...)


All too true.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
131 visitors (0 registered, 131 guests [including 52 identified bots]).
Forum time: 23:50 CEST (Europe/Vienna)

In theory, there is no difference between theory and practice.
But, in practice, there is.    Jan L.A. van de Snepscheut

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5